Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
“… vitamin D … EPO co-supplementation group had significant increases in serum 25-hydroxyvitamin D (25(OH)D) (+10.7 ± 8.4 vs. −0.5 ± 1.6 … ± 0.4, p = 0.02), and malondialdehyde (MDA) concentration (−0.4 ± 0.4 vs. +0.5 ± 1.8 µmol/L, p = 0.008).”
“After 6 weeks of intervention, changes in fasting plasma glucose (−3.6 ± 7.5 vs. +1.5 ± 11.4 mg/dL, P = 0.… = 0.007) and the quantitative insulin sensitivity check index (+0.01 ± 0.02 vs. −0.01 ± 0.02, P = 0.007) in the vitamin D … EPO ….”